Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02367456
Title A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In 1st Line MDS, AML and CMML Patients
Acronym BRIGHT 1012
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pfizer
Indications
Therapies
Age Groups: adult
Covered Countries USA | GBR | FRA | DEU | CAN | BEL


No variant requirements are available.